脉冲染料激光有效治疗Fox-Fordyce病

T. Uzunçakmak, A. Karadağ, E. Ozlu, N. Akdeniz, Bengu Cobanoglu Simsek
{"title":"脉冲染料激光有效治疗Fox-Fordyce病","authors":"T. Uzunçakmak, A. Karadağ, E. Ozlu, N. Akdeniz, Bengu Cobanoglu Simsek","doi":"10.1111/phpp.12272","DOIUrl":null,"url":null,"abstract":"Dear Sir, Fox–Fordyce disease (FFD) is a rare inflammatory disorder of apocrine sweat glands, which is clinically characterized by smooth, uniform, firm, folliculocentric, yellow skin-colored papules on apocrine gland-bearing areas (1). Etiology of FFD is still unclear, but epidemiologic data support the role of hormonal component (1, 2). FFD is a treatment-resistant disease, and no certain treatment method has been proven to be curative. Topical and intralesional glucocorticoids, topical and systemic retinoids, topical clindamycin, topical pimecrolimus cream, benzoyl peroxide, oral contraceptives, oral isotretinoin, and ablative lasers have been reported with varying efficacy portion. In recalcictrant cases, mechanical destruction or removal of the apocrine glands can be offered. Pulsed dye laser is a gold standard treatment method for vascular lesions which was first used in the treatment of telangiectatic chronic erythema in 1996 (3). Today, we can use this laser in many different indications both in vascular, inflammatory, and tumoral etiology (4, 5). Effect of this laser has not been reported in the literature before. We want to present a young female patient with Fox–Fordyce disease with good response to pulsed dye laser. A 17-year-old female patient admitted to our outpatient clinic with a 2-year history of no hair growth and no sweating on bilaterally axillar region with excessive itching. Dermatological examination revealed multiple, follicular, skin-colored, 1to 2-mm-diameter papular lesions on bilateral axillary fossa (Fig. 1). Histopathological examination revealed mild dilatation and mild fibrosis in eccrine sweat glands, perifollicular fibrosis and chronic inflammation (Fig. 2). She was diagnosed as FFD with her histological and clinical examinations and topical clobetasol propionate ointment was initiated. In second month of this therapy, no remission was detected and topical pimecrolimus was offered but she could not use this therapy because of irritation. We started pulsed dye laser application (585 nm), 6 weeks apart, with 8 J/cm and after first session both hair growth and sweating were detected, after third session itching was significantly decreased (Figs 3 and 4). We evaluated the clinical response by hair growth clinically and symptomatic decrease of pruritus. The severity of itching was evaluated with visual analog scale which was 10/10 at the beginning and we observe a slow decrease in itching after every session. Her VAS score was 9/10 after first session, 8/10 after second session, 7/10 after third session, 6/10 after fourth session, and 5/10 after fifth session. After sixth session, her itching was 3/10 and almost total remission was detected in pruritus after","PeriodicalId":20060,"journal":{"name":"Photodermatology","volume":"12 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2016-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"7","resultStr":"{\"title\":\"Effective treatment of Fox–Fordyce disease with pulsed dye laser\",\"authors\":\"T. Uzunçakmak, A. Karadağ, E. Ozlu, N. Akdeniz, Bengu Cobanoglu Simsek\",\"doi\":\"10.1111/phpp.12272\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Dear Sir, Fox–Fordyce disease (FFD) is a rare inflammatory disorder of apocrine sweat glands, which is clinically characterized by smooth, uniform, firm, folliculocentric, yellow skin-colored papules on apocrine gland-bearing areas (1). Etiology of FFD is still unclear, but epidemiologic data support the role of hormonal component (1, 2). FFD is a treatment-resistant disease, and no certain treatment method has been proven to be curative. Topical and intralesional glucocorticoids, topical and systemic retinoids, topical clindamycin, topical pimecrolimus cream, benzoyl peroxide, oral contraceptives, oral isotretinoin, and ablative lasers have been reported with varying efficacy portion. In recalcictrant cases, mechanical destruction or removal of the apocrine glands can be offered. Pulsed dye laser is a gold standard treatment method for vascular lesions which was first used in the treatment of telangiectatic chronic erythema in 1996 (3). Today, we can use this laser in many different indications both in vascular, inflammatory, and tumoral etiology (4, 5). Effect of this laser has not been reported in the literature before. We want to present a young female patient with Fox–Fordyce disease with good response to pulsed dye laser. A 17-year-old female patient admitted to our outpatient clinic with a 2-year history of no hair growth and no sweating on bilaterally axillar region with excessive itching. Dermatological examination revealed multiple, follicular, skin-colored, 1to 2-mm-diameter papular lesions on bilateral axillary fossa (Fig. 1). Histopathological examination revealed mild dilatation and mild fibrosis in eccrine sweat glands, perifollicular fibrosis and chronic inflammation (Fig. 2). She was diagnosed as FFD with her histological and clinical examinations and topical clobetasol propionate ointment was initiated. In second month of this therapy, no remission was detected and topical pimecrolimus was offered but she could not use this therapy because of irritation. We started pulsed dye laser application (585 nm), 6 weeks apart, with 8 J/cm and after first session both hair growth and sweating were detected, after third session itching was significantly decreased (Figs 3 and 4). We evaluated the clinical response by hair growth clinically and symptomatic decrease of pruritus. The severity of itching was evaluated with visual analog scale which was 10/10 at the beginning and we observe a slow decrease in itching after every session. Her VAS score was 9/10 after first session, 8/10 after second session, 7/10 after third session, 6/10 after fourth session, and 5/10 after fifth session. After sixth session, her itching was 3/10 and almost total remission was detected in pruritus after\",\"PeriodicalId\":20060,\"journal\":{\"name\":\"Photodermatology\",\"volume\":\"12 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2016-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"7\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Photodermatology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1111/phpp.12272\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Photodermatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1111/phpp.12272","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 7

摘要

尊敬的先生,Fox-Fordyce病(FFD)是一种罕见的大汗腺炎症性疾病,临床表现为大汗腺分泌部位出现光滑、均匀、紧实、以卵泡为中心、皮肤颜色呈黄色的丘疹(1)。FFD的病因尚不清楚,但流行病学资料支持激素成分的作用(1,2)。FFD是一种难治性疾病,目前还没有某种治疗方法被证实可以治愈。局部和病灶内糖皮质激素、局部和全身类维生素a、局部克林霉素、局部吡美莫司乳膏、过氧化苯甲酰、口服避孕药、口服异维甲酸和烧蚀激光均有不同疗效部分的报道。在顽固性病例中,可以采用机械破坏或切除大汗腺的方法。脉冲染料激光是治疗血管病变的金标准方法,1996年首次用于治疗毛细血管扩张性慢性红斑(3)。今天,我们可以在血管、炎症和肿瘤病因的许多不同适应症中使用这种激光(4,5)。这种激光的效果在以前的文献中没有报道过。我们想报告一位年轻的女性福克斯-福代斯病患者对脉冲染料激光有良好的反应。一名17岁的女性患者因2年无毛发生长,双侧腋窝无汗液伴过度瘙痒而入院。皮肤病学检查示双侧腋窝多发,滤泡性,皮肤色,直径1 ~ 2mm丘疹病变(图1)。组织病理学检查示分泌汗腺轻度扩张,轻度纤维化,滤泡周围纤维化,慢性炎症(图2)。经组织学和临床检查诊断为FFD,并开始外用丙酸氯倍他索软膏。在该治疗的第二个月,没有发现缓解,并提供局部吡美莫司,但由于刺激不能使用该治疗。我们开始使用脉冲染料激光(585 nm),间隔6周,8 J/cm,第一次治疗后检测到毛发生长和出汗,第三次治疗后瘙痒明显减少(图3和4)。我们通过临床毛发生长和瘙痒症状减轻来评估临床反应。瘙痒的严重程度用视觉模拟量表评估,开始时为10/10,我们观察到每次疗程后瘙痒缓慢下降。第一疗程后VAS评分为9/10,第二疗程后为8/10,第三疗程后为7/10,第四疗程后为6/10,第五疗程后为5/10。第6次治疗后,患者瘙痒程度为3/10,瘙痒几乎完全缓解
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Effective treatment of Fox–Fordyce disease with pulsed dye laser
Dear Sir, Fox–Fordyce disease (FFD) is a rare inflammatory disorder of apocrine sweat glands, which is clinically characterized by smooth, uniform, firm, folliculocentric, yellow skin-colored papules on apocrine gland-bearing areas (1). Etiology of FFD is still unclear, but epidemiologic data support the role of hormonal component (1, 2). FFD is a treatment-resistant disease, and no certain treatment method has been proven to be curative. Topical and intralesional glucocorticoids, topical and systemic retinoids, topical clindamycin, topical pimecrolimus cream, benzoyl peroxide, oral contraceptives, oral isotretinoin, and ablative lasers have been reported with varying efficacy portion. In recalcictrant cases, mechanical destruction or removal of the apocrine glands can be offered. Pulsed dye laser is a gold standard treatment method for vascular lesions which was first used in the treatment of telangiectatic chronic erythema in 1996 (3). Today, we can use this laser in many different indications both in vascular, inflammatory, and tumoral etiology (4, 5). Effect of this laser has not been reported in the literature before. We want to present a young female patient with Fox–Fordyce disease with good response to pulsed dye laser. A 17-year-old female patient admitted to our outpatient clinic with a 2-year history of no hair growth and no sweating on bilaterally axillar region with excessive itching. Dermatological examination revealed multiple, follicular, skin-colored, 1to 2-mm-diameter papular lesions on bilateral axillary fossa (Fig. 1). Histopathological examination revealed mild dilatation and mild fibrosis in eccrine sweat glands, perifollicular fibrosis and chronic inflammation (Fig. 2). She was diagnosed as FFD with her histological and clinical examinations and topical clobetasol propionate ointment was initiated. In second month of this therapy, no remission was detected and topical pimecrolimus was offered but she could not use this therapy because of irritation. We started pulsed dye laser application (585 nm), 6 weeks apart, with 8 J/cm and after first session both hair growth and sweating were detected, after third session itching was significantly decreased (Figs 3 and 4). We evaluated the clinical response by hair growth clinically and symptomatic decrease of pruritus. The severity of itching was evaluated with visual analog scale which was 10/10 at the beginning and we observe a slow decrease in itching after every session. Her VAS score was 9/10 after first session, 8/10 after second session, 7/10 after third session, 6/10 after fourth session, and 5/10 after fifth session. After sixth session, her itching was 3/10 and almost total remission was detected in pruritus after
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信